S. Williams

Injection Drug Use-Associated Candidemia: Incidence, Clinical Features, and Outcomes, East Tennessee, 2014-2018.

W. Schaffner, B. Jackson, J. Rossow, 2020, Journal of Infectious Diseases.

The Changing Epidemiology of Candidemia in the United States: Injection Drug Use as an Increasingly Common Risk Factor - Active Surveillance in Selected Sites, United States, 2014-17.

W. Schaffner, B. Jackson, J. Nadle, 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Population-Based Active Surveillance for Culture-Confirmed Candidemia — Four Sites, United States, 2012–2016

Brendan R. Jackson, W. Schaffner, B. Jackson, 2019, Morbidity and mortality weekly report. Surveillance summaries.

A Tale of Two Healthcare-associated Infections: Clostridium difficile Coinfection Among Patients With Candidemia

W. Schaffner, Z. Beldavs, G. Dumyati, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Burden of Candidemia in the United States, 2017.

Brendan R. Jackson, W. Schaffner, B. Jackson, 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Candida Bloodstream Infections Among Persons Who Inject Drugs — Denver Metropolitan Area, Colorado, 2017–2018

W. Bamberg, D. Barter, S. Vallabhaneni, 2019, MMWR. Morbidity and mortality weekly report.

363. National Burden of Candidemia, United States, 2017

W. Schaffner, S. Magill, G. Dumyati, 2018, Open Forum Infectious Diseases.

1722. The Changing Epidemiology of Candidemia in the United States: Injection Drug Use as an Emerging Risk Factor for Candidemia

W. Schaffner, B. Jackson, G. Dumyati, 2018, Open Forum Infectious Diseases.